Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.
MMJ Program Summary
Transcript of MMJ Program Summary
NYS Medical Marijuana Program
Lisa Valle MS, Ed.
Jeffrey Lombardo, PharmD., BCOP
Daniel Ryszka RPh.
And….so that patient's should NEVER have to suffer!
Cost of the medications: not covered by insurance ($300-1,200/month)
Locations: 20 throughout all NYS. Bad weather? Shortages? Patients are driving up to 8 hours round trip
Variable Strains: 5 companies each producing “their” brand, not all are open, and have a full line of products
The registered organizations are not providing the patients with a comprehensive strain profile for the product they are receiving
Limited qualifying conditions
Not enough providers: Approximately 90,000 doctors in NYS. As of 5/9/16 only 564 are registered providers for a population of 80 million people living in NYS
Hospital admission: Need clear guidance from the DOH regarding handling procedures
Schools: Need guidance from the DOH regarding safehandling of product if a dose is required in school
Lack of transparency from the DOH
Concerns and Issues
Where will the Registered Organizations and Dispensing Facilities be located?
Allow states to legalize marijuana for medical use without federal interference
Permit interstate commerce in cannabidiol (CBD) oils
Reschedule marijuana to schedule II
Allow banks to provide checking accounts and other financial services to marijuana dispensaries
Allow Veterans Administration physicians to recommend medical marijuana to veterans
Eliminate barriers to medical marijuana research
tates Act (CARERS)
Cannabinadiolic acid (CBDA)
Cannabinol ( CBN)
Tetrahydrocannabinol acid (THCA)
At a minimum the concentrations for the following cannabinoids must be reported in the final brand, in it’s final form:
NYS reportable cannabinoid profile
3. Capsules for oral administration
2. Metered liquid or oil preparations for vaporization
1. Liquid or oil preparations for oromucosal, sublingual, or per tube
July 2014 Governor Cuomo approved the Compassionate Care Act in NYS
July 2015 Five (5) Registered Organizations (RO) allowed to grow and manufacture medical marijuana
Each RO allowed to provide product to 4 Dispensing Facilities (20 in total across NYS)
Each RO can only produce 5 strains (mandatory: 1 strain low THC and high CBD (e.g. 1:20) and 1 strain of equal THC and CBD)
Each brand shall have a maximum of 10mg total THC per dose
Anticipated start date: January 5, 2016. Actually started January 7, 2016
Why did we get involved with cannabis as medicine?
Presumptions of Marijuana
Reality of Cannabis
Visit us on Facebook at:
Medical Cannabis Connection of NY
Psychoactive Cannabinoids Non-psychoactive Cannabinoids
Any other cannabinoid component at >0.1%
There are 62 counties in New York and only 13 have a dispensing facility.
Not all dispensing facilites are open.
Dispensing Facilities do not have a full product line per regulations.
The City of Buffalo, the 2nd largest city in New York State does not have a Dispensing Facility or Registered Organization.
Each Registered Organization is producing different products.
Patient Safety Organizations
Collaboration with providers, patients, dispensing facilities and academic institutions to provide safety and monitoring
Additional assistance with applications, registration, and follow up care
Added security with drug interaction monitoring
Amyotrophic lateral sclerosis (ALS)
Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity
Inflammatory bowel disease
Any condition added by the Commissioner of Health
NYS Approved Severe Debilitating or Life-threatening Conditions For Use